FDA NDC Directory · JSON-LD · Markdown
NDC 70860-211 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION
| Generic name | fulvestrant |
|---|---|
| Labeler / Manufacturer | Athenex Pharmaceutical Division, LLC. |
| Marketing category | Abbreviated NDA (generic) · App ANDA211422 |
| Dosage form / route | INJECTION, SOLUTION · INTRAMUSCULAR |
| Active ingredients | FULVESTRANT (50 mg/mL) |
| Marketing started | 20200218 |
| Marketing ended | 20261231 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).